Yahoo Finance

For the quarter ended March 2025, Evolent Health (EVH) reported revenue of $483.65 million, down 24.4% over the same period last year. EPS came in at $0.06, compared to $0.34 in the year-ago quarter.

The reported revenue represents a surprise of +4.76% over the Zacks Consensus Estimate of $461.69 million. With the consensus EPS estimate being $0.09, the EPS surprise was -33.33%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Evolent Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Average PMPM Fees / Revenue per Case - Performance Suite: $15.57 versus $16.14 estimated by three analysts on average.

• Average PMPM Fees / Revenue per Case - Specialty Technology and Services Suite: $0.36 versus the three-analyst average estimate of $0.38.

• Average PMPM Fees / Revenue per Case - Administrative Services: $15.72 compared to the $15.87 average estimate based on three analysts.

• Average Lives on Platform / Cases - Cases: 14 thousand compared to the 14.88 thousand average estimate based on three analysts.

• Average Lives on Platform / Cases - Performance Suite: 6.49 million versus 5.72 million estimated by three analysts on average.

• Average Lives on Platform / Cases - Specialty Technology and Services Suite: 77.08 million compared to the 73.62 million average estimate based on three analysts.

• Average Lives on Platform / Cases - Administrative Services: 1.21 million versus 1.2 million estimated by three analysts on average.

• Average PMPM Fees / Revenue per Case - Cases: $2,947 versus the three-analyst average estimate of $2,957.33.

• Total Revenue by product type- Performance Suite: $303.02 million versus $275.18 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -32.4% change.

• Total Revenue by product type- Cases: $40.62 million compared to the $43.93 million average estimate based on three analysts. The reported number represents a change of -7.4% year over year.

• Total Revenue by product type- Administrative Services: $57.19 million versus the three-analyst average estimate of $59.48 million. The reported number represents a year-over-year change of -2.4%.

• Total Revenue by product type- Specialty Technology and Services Suite: $82.82 million versus $83.47 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -7% change.